About New & Emerging Therapies (NET) Clinic
Advanced Mental Health, Memory and Mobility Treatments
Robina Private Hospital is proud to introduce the New & Emerging Therapies (NET) Clinic, a dedicated space for pioneering treatments that support patients with complex mental health, cognitive and mobility challenges.
Our multidisciplinary team of specialists offers comprehensive assessments, personalised treatment plans and ongoing monitoring to ensure the safety and effectiveness of these advanced therapies.
Why Choose the NET Clinic?
- Access to cutting-edge therapies not widely available
- Delivered by a highly experienced clinical team
- Focused on improving quality of life and long-term outcomes
Whether you're seeking support for persistent depression, early memory changes, or rehabilitation for reduced mobility, the NET Clinic offers hope through innovation.
Treatments
- Emerging therapies for Treatment Resistant Depression (TRD)
- Evidence-based interventions for Mild Cognitive Impairment (MCI) and mild dementia
- Robotic-Assisted Rehabilitation Therapy for mobility-related conditions
Treatment Resistant Depression (TRD)
Transcranial magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression.
TMS is typically used when other depression treatments haven’t been effective. TMS involved stimulation of an area of your brain using a pulsing magnet placed on your scalp. The magnet is designed to give a focused beam of magnetic energy inducing small electrical currents with the aim of altering brain function for therapeutic purposes.
TMS works by changing the brain electrical activity and the brain chemicals that are involved in controlling mood.
Read more
Robotic-Assisted Rehabilitation Therapy
Robina Private Hospital offers highly intensive, focused and motivating robotic-assisted rehabilitation for patients with neurological and mobility-related conditions.
Led by Dr Jom Jiao, Director of Rehabilitation, the program enhances traditional rehabilitation by increasing the number of repetitions during therapy—key to achieving faster and more effective recovery outcomes.
Key features:
- Combines robotics, virtual reality and gamification to engage patients both physically and cognitively.
- Targets conditions such as stroke, spinal cord injury, Parkinson’s disease, and Multiple Sclerosis.
- Focuses on three essential components: intensity, dose and motivation.
- Helps patients and therapists optimise therapy outcomes regardless of location or phase of recovery.
This innovative approach is designed to accelerate recovery, improve mobility, and support long-term rehabilitation goals through personalised, evidence-based care.
Read more
Robotic Assisted Rehabilitation
Esketamine Therapy
Esketamine nasal spray is listed on the ARTG and is a Schedule 8 controlled medicine (1). It can only be administered at approved treatment centres such as ours, where key training and assessment requirements have been completed.
Esketamine nasal spray is indicated for treatment resistant depression (Major Depressive Disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode). Esketamine nasal spray is to be initiated in conjunction with a newly initiated oral antidepressant. (1)
Reference: (1.)Esketamine Nasal Spray Approved Product Information.
Specialties
- Mental health
- Rehabilitation
Address
Physical Address
New & Emerging Therapies (NET) Clinic